Abbott Laboratories stock after-hours at EUR 86.00: minus 1.21 percent versus prior close

Abbott Laboratories was at EUR 86.00 at 10:42 p.m. CEST on October 1, 2026. The after-hours price was minus 1.21 percent versus the Lang & Schwarz prior close.

The after-hours price at Lang & Schwarz was EUR 86.00 at 10:42 p.m. CEST on October 1, 2026. The change was minus 1.21 percent versus the prior close at Lang & Schwarz of EUR 87.05.

Trading day in Germany

Abbott Laboratories’ stock was quoted after-hours in euros, with the prior close at Lang & Schwarz standing at EUR 87.05. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.

SimpleScreen CRC launch

Abbott announced the U.S. commercial launch of SimpleScreen CRC on September 30, 2026, describing it as an FDA-approved blood-based colorectal cancer screening test for average-risk adults age 45 and older. The company said the test is developed and manufactured by Freenome and exclusively commercialized by Abbott. In a prespecified analysis, the test showed 81.1 percent overall sensitivity for colorectal cancer and 90.4 percent specificity for advanced colorectal neoplasia, according to the Abbott release distributed by PR Newswire.

Third-quarter reporting date

Abbott said it will announce its third-quarter 2026 financial results before the market opens on October 21, 2026. The announcement will be followed by a webcast at 8:00 a.m. Central time, or 9:00 a.m. Eastern time, according to the company’s media-room release.